HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People In Brief

This article was originally published in The Rose Sheet

Executive Summary

J&J reorganizes QC functions: New company-wide framework will help "facilitate more effective coordination of Johnson & Johnson's quality, compliance and supply chain organizations," according to Corporate Communication VP Jeffrey Leebaw. The spokesman said in an e-mail that CEO William Weldon announced the plan internally the week of Aug. 15 and appointed Corporate VP Ajit Shetty to oversee the new framework. Chief quality officers also will be named for J&J's consumer, pharmaceutical and medical device businesses, Leebaw added. Recalls of OTCs made by J&J's McNeil Consumer Healthcare subsidiary have prompted FDA and congressional investigations and the firm has spent much of 2010 addressing manufacturing shortcomings (1"The Rose Sheet" July 26, 2010)

You may also be interested in...

OTC Recalls Aside, J&J Says Business Still Burdened By Economic Factors

Johnson & Johnson concedes that even without the fallout from a recent string of OTC drug recalls, its consumer healthcare business would have been "flat to slightly down" for the quarter

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts